Amy Apostoleris

Amy Apostoleris, MBA has extensive work experience in various leadership and business development roles within the healthcare and clinical research industry. Amy began their career at Pfizer as a Healthcare Account Manager before moving on to ICON Central Laboratories as an Associate Director of Project Management. Amy then served as the Director of Business Development at the Harvard Clinical Research Institute and later became the Senior Director of Business Development at INC Research. Amy further advanced their career at INC Research as the Executive Director of Strategic Business Development and eventually joined Syneos Health as the Vice President of Strategic Development in Clinical Solutions. Amy's most recent role before their current position was as the President of HBA MetroWest New England Region at the Healthcare Businesswomen's Association. Currently, they serve as the Global Head of Digital Clinical Trials Solutions at Medocity, where they are responsible for driving revenue growth, managing operations, and overseeing clinical teams to optimize the digital clinical trials process. Additionally, Amy is an active member of the Decentralized Trials & Research Alliance's Leadership Council for the DCT KPIs Initiative.

Amy Apostoleris holds a Bachelor of Arts (B.A.) degree in Human Ecology and Botany from Connecticut College. Amy also has a Master of Business Administration (MBA) degree with a specialization in Pharmaceutical Sciences and Healthcare from Saint Joseph's University - Erivan K. Haub School of Business. Additionally, they have a Master of Arts (M.A.) degree in Education and Life Sciences from Connecticut College.